Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

HDA ANNOUNCES APPOINTMENTS TO EXECUTIVE COMMITTEE, FOUNDATION BOARD OF DIRECTORS

The Healthcare Distribution Alliance (HDA) today announced the following appointments to its Executive Committee and HDA Research Foundation Board of Directors:

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

HDA Executive Committee
 

  • Paul M. Dickson, President, Morris & Dickson Co., L.L.C., was elected a member of the HDA Executive Committee. Dickson is a current member of the Alliance’s Board of Directors.

HDA Research Foundation Board of Directors
 

  • James Reilly, Vice President, Access & Channel Management, Genentech, Inc., A Member of the Roche Group, and Greg Drew, President, Value Drug Company, were elected Chairman and Vice Chairman of the Foundation Board of Directors, respectively.
  • Craig Cowman, Executive Vice President, Global Sourcing, Cardinal Health, Inc., and Jeffrey Hampton, Senior Vice President, General Manager, US & LATAM, Apotex Corp., join as Directors.
     

John M. Gray, President and CEO, HDA, noted, “All of these individuals bring enormous talent and experience that will help guide our organization in support of protecting patient safety and enhancing supply chain efficiencies. I look forward to working with them in the months ahead.”

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?